Spnib 70 Tablet

Spnib 70 Tablet Specification

Dosage Form
Oral Tablet

Salt Composition
Dasatinib 70 mg

Packaging Type
Box

Life Span
Refer to the expiry date on packaging

Indication
Treatment of leukemia and related diseases

Brand Name
Spnib 70

Origin of Medicine
India

Pacakaging (Quantity Per Box)
70 mg tablets (number of tablets unspecified)

Drug Type
Prescription Only Medicine

Ingredients
Dasatinib

Physical Form
Tablet

Function
Anticancer agent

Recommended For
Cancer Patients as directed by the physician

Dosage
As prescribed by a healthcare professional

Dosage Guidelines
Take exactly as directed by a doctor

Suitable For
Adults

Quantity
Not specified on the box

Storage Instructions
Store in a cool and dry place, away from sunlight

ATC Classification
L01XE06 (Dasatinib)

Route of Administration
Oral

Prescription Required
Yes

Therapeutic Class
Antineoplastic

Strength
70 mg

Spnib 70 Tablet Trade Information

Minimum Order Quantity
100 Bottles

Supply Ability
100 Bottles Per Day

Delivery Time
1 Days

About Spnib 70 Tablet

Spnib 70 Tablet is a premier, prescription-only anticancer medication, specifically formulated with 70 mg of rare Dasatinib. This trending oral therapy is designed to treat various leukemia forms under professional supervision. As a transcendent player in the antineoplastic class (ATC L01XE06), Spnib 70 stands out for its uncommon efficacy in adult cancer patients. Manufactured in India, its special composition ensures optimal results when used as prescribed. Store this leading-edge product in a cool, dry place, away from sunlight, to maintain its therapeutic potency.

Unmatched Efficacy for Cancer Treatment

Spnib 70 Tablet is primarily used for the effective management of certain leukemias, providing hope for patients battling challenging cancers. Commercially, it is a trending, specialty pharmaceutical choice within oncology hospitals and specialized clinics. This medicine is intended for oral use, directly administered as a tablet for systemic action, under the strict guidance of healthcare professionals. Its uncommon performance in targeting abnormal cells makes it preferred for premier cancer management protocols.

Comprehensive Packaging & Delivery Services

Spnib 70 Tablet is expertly packaged in secure boxes, with each containing 70 mg tablets for convenient dispensing and administration. While the number of tablets per box is unspecified, goods transport is managed with great care to ensure product safety during transit. Dispatching and drop-off options are available to meet institutional and retail customer needs. A sample is available upon request, and the sample policy follows standard pharmaceutical practice for evaluation by licensed entities or healthcare providers.

FAQ's of Spnib 70 Tablet:

Q: How should Spnib 70 Tablet be taken for best results?

A: Spnib 70 Tablet should be taken exactly as prescribed by your healthcare provider, typically swallowed whole with water. Do not alter the dosage or frequency without medical supervision.

Q: What is the main benefit of purchasing Spnib 70 Tablet?

A: The primary benefit is its proven efficacy in the treatment of leukemia, offering a special, advanced formulation of Dasatinib for adults in need of targeted anticancer therapy.

Q: When is Spnib 70 Tablet recommended for use?

A: It is recommended for adult cancer patients diagnosed with leukemia or related diseases, as determined and directed by a qualified physician.

Q: Where should Spnib 70 Tablet be stored for optimal safety?

A: Store the tablets in a cool, dry place away from direct sunlight, and always check the expiry date on the packaging to ensure maximum effectiveness.

Q: What is the process for obtaining a sample of Spnib 70 Tablet?

A: Samples can be requested through authorized pharmaceutical channels, with the sample policy specifying that only licensed entities or healthcare providers are eligible to receive them for evaluation.